Marva Moxey-Mims
Pediatric Nephrology · Washington, DCNPI 1639609910
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (52.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Travere Therapeutics, Inc. accounts for 83.0% of it on its own, with 6 other manufacturers making up the rest.
Across 41 payments — averaging $275.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Travere Therapeutics, Inc.$9K
- Bayer$2K
- AstraZeneca$166
- Outset Medical Inc$75
- Vertex$73
- Aurinia Pharma U.S., Inc.$34
- plus $23 from 1 others
Across 53 payments — averaging $4052.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Vertex$55K
- Travere Therapeutics, Inc.$52K
- Hoffmann-la Roche Limited$42K
- Bayer$30K
- AbbVie$26K
- Rockwell Medical, Inc.$9K
What the payments were for
- Consulting fees$5,90052%
- Speaking & faculty fees$1501%
- Travel & lodging$3,52731%
- Food & beverage$1,70115%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Travere Therapeutics, Inc. | 22 | $9,362 |
| Bayer | 12 | $1,545 |
| AstraZeneca | 2 | $166 |
| Outset Medical Inc | 2 | $75 |
| Vertex | 1 | $73 |
| Aurinia Pharma U.S., Inc. | 1 | $34 |
| Apellis Pharmaceuticals, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few pediatric nephrology providers in District of Columbiato place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProcritEpoetin Alfa | 14 | $13,380 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $23 |
Paid to pharmacies, not to this prescriber.
Other pediatric nephrology in Washington
- Lisa Guay-WoodfordWashington$28K
- Asha MoudgilWashington$3K
- Denver BrownWashington$536
- Celina BrunsonWashington$253
- Yi ShiWashington$115
- Anuradha GajjarWashington$110
- Sarah RogalWashington$83
- Ashima GulatiWashington$53
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.